scholarly journals The autistic-like behaviors development during weaning and sexual maturation in VPA-induced autistic-like rats is accompanied by gut microbiota dysbiosis

PeerJ ◽  
2021 ◽  
Vol 9 ◽  
pp. e11103
Author(s):  
Qingmin Kong ◽  
Peijun Tian ◽  
Jianxin Zhao ◽  
Hao Zhang ◽  
Gang Wang ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Propionic Acid ◽  
Butyric Acid ◽  
Sexual Maturation ◽  
Developmental Disorders ◽  
Acid Metabolism ◽  
Inositol Phosphate ◽  
Age Groups ◽  
Short Chain Fatty Acids ◽  
Inositol Phosphate Metabolism

Researches on gut microbiota in autism have mostly focused on children, but the dynamic changes of gut microbiota from weaning to adulthood were still not clear because of the difficulty of diagnosing autism. In this study, autistic-like rats indued by valproate (VPA) were tracked from weaning (end of breastfeeding; four weeks old) to sexual maturation (food; eight weeks old). Autistic-like rats were found to show obvious developmental disorders. During weaning, autistic-like rats only exhibited obvious repetitive stereotyped behaviors, but the autistic-like behaviors were fully apparent upon sexual maturation. Significant differences were observed between the gut microbiota of autistic-like and healthy rats across both age groups. The correlation analysis results revealed that the correlation between behaviors and some microbiota, especially Helicobacter, did not vary with age or diet. The total amount of short-chain fatty acids (SCFAs) decreased, butyric acid metabolism decreased, and propionic acid metabolism increased in the feces of autistic-like rats. The correlation between autistic-like behaviors and the butyric acid and propionic acid levels did not vary with diet or age. Inositol phosphate metabolism, amino acid metabolism, and lipopolysaccharide biosynthesis were significantly associated with autistic-like behaviors. Our results showed that although the microbiota and SCFAs related to autism were affected by age and diet, some remained consistent irrespective of age and diet, and they could be considered two of the factors related to autistic-like behaviors development.

scholarly journals Qiweibaizhu Decoction Treats Diarrheal Juvenile Rats by Modulating the Gut Microbiota, Short-Chain Fatty Acids, and the Mucus Barrier

2021 ◽  
Vol 2021 ◽  
pp. 1-15
Author(s):  
Shaodan Sun ◽  
Yang Yang ◽  
Xiaojie Lin ◽  
Peiwen Chen ◽  
Liyan Ye ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Acetic Acid ◽  
Gut Microbiota ◽  
Propionic Acid ◽  
Butyric Acid ◽  
Intestinal Flora ◽  
Short Chain Fatty Acids ◽  
Short Chain ◽  
Juvenile Rats ◽  
Mucus Barrier

Background. Qiweibaizhu decoction (QBD), a classic Chinese herbal formula, has been widely used for treating diarrhea in infants and children with spleen deficiency syndrome for centuries, but its mechanism of action remains unclear. The gut microbiota, short-chain fatty acids (SCFAs), and intestinal mucus are closely associated with diarrhea. Methods. In this study, the composition of the gut microbiota in diarrheal rats was analyzed by 16S rDNA amplicon sequencing. The concentrations of colon SCFAs were determined using gas chromatography-mass spectrometry (GC-MS). The expression of mucin 2 (MUC2) in the colon was detected by immunofluorescence. Results. Diarrhea significantly changed the diversity and structure of the gut microbiota and disrupted the mucus barrier in juvenile rats. QBD did not significantly change the diversity and structure of the intestinal flora, but it enhanced the increasing tendencies of Verrucomicrobia and Akkermansia and decreased the abundance of Turicibacter ( P = 0.037 ) and Flavonifractor ( P = 0.043 ). QBD tends to repair the mucus layer and promote MUC2 expression in juvenile rats with diarrhea. Moreover, S. boulardii significantly increased the abundance of Parasutterella ( P = 0.043 ). In addition, QBD treatment tends to increase the propionic acid concentration during diarrhea, but its levels of acetic acid, propionic acid, butyric acid, and total SCFAs were lower than those in the S. boulardii group. Conclusion. S. boulardii significantly increased the abundance of Parasutterella, leading to increased production of acetic acid, propionic acid, and butyric acid, consequently leading to alleviation of diarrhea. In comparison, QBD affected diarrhea via regulation of the intestinal flora, especially by increasing the abundance of Verrucomicrobia and Akkermansia, resulting in mucus barrier repair, protection of the intestines, and treatment of diarrhea.

scholarly journals Short Chain Fatty Acids Commonly Produced by Gut Microbiota Influence Salmonella enterica Motility, Biofilm Formation, and Gene Expression

Antibiotics ◽  
2019 ◽  
Vol 8 (4) ◽  
pp. 265 ◽  
Author(s):  
Alexandre Lamas ◽  
Patricia Regal ◽  
Beatriz Vázquez ◽  
Alberto Cepeda ◽  
Carlos Manuel Franco
Keyword(s):  
Gene Expression ◽  
Fatty Acids ◽  
Antimicrobial Activity ◽  
Acetic Acid ◽  
Gut Microbiota ◽  
Propionic Acid ◽  
Butyric Acid ◽  
Biofilm Formation ◽  
Short Chain Fatty Acids ◽  
Subinhibitory Concentrations

Short chain fatty acids (SCFAs) are commonly produced by healthy gut microbiota and they have a protective role against enteric pathogens. SCFAs also have direct antimicrobial activity against bacterial pathogens by diffusion across the bacterial membrane and reduction of intracellular pH. Due to this antimicrobial activity, SCFAs have promising applications in human health and food safety. In this study, the minimum inhibitory concentrations (MICs) of four SCFAs (acetic acid, butyric acid, propionic acid, and valeric acid) in Salmonella strains isolated from poultry were determined. The effect of subinhibitory concentrations of SCFAs in Salmonella biofilm formation, motility, and gene expression was also evaluated. Butyric acid, propionic acid, and valeric acid showed a MIC of 3750 µg/mL in all strains tested, while the MIC of acetic acid was between 1875 and 3750 µg/mL. Subinhibitory concentrations of SCFAs significantly (p < 0.05) reduced the motility of all Salmonella strains, especially in the presence of acetic acid. Biofilm formation was also significantly (p < 0.05) lower in the presence of SCFAs in some of the Salmonella strains. Salmonella strain. Salmonella Typhimurium T7 showed significant (p < 0.05) upregulation of important virulence genes, such as invA and hilA, especially in the presence of butyric acid. Therefore, SCFAs are promising substances for the inhibition of the growth of foodborne pathogens. However, it is important to avoid the use of subinhibitory concentrations that could increase the virulence of foodborne pathogen Salmonella.

scholarly journals Dietary and anthropometric factors affecting the potential of gut microbiota to utilize dietary fiber and produce short-chain fatty acids

2020 ◽  
Vol 79 (OCE2) ◽  
Author(s):  
Anna M. Malinowska ◽  
Marcin Schmidt ◽  
Malgorzata Majcher ◽  
Hanna Przydatek ◽  
Marta Szaban ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Acetic Acid ◽  
Gut Microbiota ◽  
Dietary Fiber ◽  
Propionic Acid ◽  
Butyric Acid ◽  
Dietary Pattern ◽  
Short Chain Fatty Acids ◽  
Short Chain ◽  
Chain Fatty Acids

AbstractSome species of gut bacteria produce short-chain fatty acids (SCFAs) from dietary fiber—mainly acetate, propionate, and butyrate. The composition of human gut microbiota is dependent on dietary intake and health status. The aim of this study was to assess the effect of diet and anthropometric parameters on the potential of gut microbiota to metabolize dietary fiber and produce SCFA.A group of 200 men and women aged 31 to 50 years old participated in the study. The diet was assessed using three-day dietary records and the dietary pattern was determined using score methods. The potential to utilize water-insoluble fiber was assessed by measuring the β-glucosidase enzymatic activity of dissolved feces. To estimate the potential to metabolize water-soluble dietary fiber, cultures containing feces and pectin were incubated under anaerobic conditions for 24 hours. The amounts of fiber, acetic acid, propionic acid, and butyric acid before and after incubation were measured.Pectin utilization correlated positively with the amount of energy intake from fat (r = 0.19) and with the intake of nuts and seeds (r = 0.17) and was negatively correlated with the amount of energy from complex carbohydrates (r = -0.16) and its sources, such as refined grain products (r = -0.15). The dietary pattern did not affect the potential of the gut microbiota to metabolize pectin, but did influence the potential to digest insoluble dietary fiber, as the subjects following the western dietary pattern had lower potential than those following the rational pattern. β-glucosidase activity correlated positively with the intake of dietary fiber (r = 0.19) and intake of its sources, such as fruits (r = 0.18), vegetables (r = 0.21), and nuts and seeds (r = 0.18); it correlated negatively with nonalcoholic beverage intake (r = -0.15) and sugar and honey intake (r = -0.16). The potential to synthesize acetic acid correlated negatively with dietary indices and dietary fiber intake (r = -0.18). The potential to synthesize propionic acid correlated negatively with hip and waist circumference (r = -0.14, -0.15, respectively). The potentials to synthesize both propionic and butyric acid were affected by the intake of nuts and seeds (r = 0.18, 0.21, respectively).Diet affects the potential of gut microbiota to utilize dietary fiber and to produce SCFAs. The impact of anthropometry parameters was only seen on the potential to synthesize propionic acid.

scholarly journals Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy

2021 ◽  
Author(s):  
Lingxiong Chai ◽  
Qun Luo ◽  
Kedan Cai ◽  
Kaiyue Wang ◽  
Binbin Xu
Keyword(s):  
Gut Microbiota ◽  
Iga Nephropathy ◽  
Butyric Acid ◽  
Intestinal Flora ◽  
Short Chain Fatty Acids ◽  
Caproic Acid ◽  
Isobutyric Acid ◽  
Control Group ◽  
Β Diversity

Abstract Background: IgA nephropathy(IgAN)) is the common pathological type of glomerular diseases. The role of gut microbiota in mediating "gut-IgA nephropathy" has not received sufficient attention in the previous studies. The purpose of this study was to investigate the changes of fecal short-chain fatty acids(SCFAs), a metabolite of the intestinal microbiota, in patients with IgAN and its correlation with intestinal flora and clinical indicators, and to further investigate the role of the gut-renal axis in IgAN.Methods: There were 29 patients with IgAN and 29 normal control subjects recruited from January 2018 to May 2018. The fresh feces were collected. The fecal SCFAs were measured by gas chromatography/mass spectrometry and gut microbiota was analysed by16S rDNA sequences, followed by estimation of α- and β-diversity. Correlation analysis was performed using the spearman’s correlation test between SCFAs and gut microbiota. Results:The levels of acetic acid, propionic acid, butyric acid, isobutyric acid and caproic acid in the IgAN patients were significantly reduced compared with control group(P<0.05). Butyric acid(r=-0.336, P=0.010) and isobutyric acid(r=-0.298, P=0.022) were negatively correlated with urea acid; butyric acid(r=-0.316, P=0.016) was negatively correlated with urea nitrogen; caproic acid(r=-0.415,P=0.025) showed negative correlation with 24-h urine protein level.Exemplified by the results of α-diversity and β-diversity, the intestinal flora of IgAN patients was significantly different from that of the control group. Acetic acid was positively associated with c_Clostridia(r=0.357, P=0.008), o_Clostridiales(r=0.357, P=0.008) and g_Eubacterium_coprostanoligenes_group(r=0.283, P=0.036). Butyric acid was positively associated with g_Alistipes (r=0.278, P=0.040). The relative abundance of those were significantly decreased in IgAN group compared to control group.Conclusion: The levels of fecal SCFAs in the IgAN patients were reduced, and correlated with clinical parameters and gut microbiota, which may be involved in the pathogenesis of IgAN, and this finding may provide a new therapeutic approach.

scholarly journals Fermentation and bulking capacity of indigestible carbohydrates: the case of inulin and oligofructose

2002 ◽  
Vol 87 (S2) ◽  
pp. S163-S168 ◽  
Author(s):  
M. Nyman
Keyword(s):  
Fatty Acids ◽  
Molecular Weight ◽  
Propionic Acid ◽  
Butyric Acid ◽  
Colonic Mucosa ◽  
Short Chain Fatty Acids ◽  
Short Chain ◽  
Acid Formation ◽  
Fresh Weight ◽  
Chain Fatty Acids

The bulking index (i.e. the increase in faecal fresh weight in gram per gram indigestible carbohydrate ingested) with oligofructose and inulin is similar to that produced with other easily fermented fibres such as pectins and gums. Most studies in man have been performed at a level of 15 g/d and more investigations on lower intakes are needed to appoint the least intake for an effect. Concerning short-chain fatty acids (SCFA) most studies have been using oligofructose and points at an increased butyric acid formation in the caecum of rats. In one study on rats with inulin high caecal proportions of propionic acid were obtained. As inulin has a higher molecular weight than oligofructose it might be speculated if this could be a reason to the different SCFA-profile formed. No effects on faecal concentrations of SCFA in humans have been revealed with inulin and oligofructose, which neither is expected as most of the SCFA formed during the fermentation already has been absorbed or utilized by the colonic mucosa.

scholarly journals Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation

2021 ◽  
Vol 12 ◽  
Author(s):  
Hao-Ming Xu ◽  
Hong-Li Huang ◽  
Jing Xu ◽  
Jie He ◽  
Chong Zhao ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Gut Microbiota ◽  
Butyric Acid ◽  
Fecal Microbiota Transplantation ◽  
Short Chain Fatty Acids ◽  
Fecal Microbiota ◽  
16S Sequencing ◽  
Α Diversity ◽  
The Impact

Fecal microbiota transplantation (FMT) can inhibit the progression of ulcerative colitis (UC). However, how FMT modulates the gut microbiota and which biomarker is valuable for evaluating the efficacy of FMT have not been clarified. This study aimed to determine the changes in the gut microbiota and their relationship with butyric acid following FMT for UC. Fecal microbiota (FM) was isolated from healthy individuals or mice and transplanted into 12 UC patients or colitis mice induced by dextran sulfate sodium (DSS). Their clinical colitis severities were monitored. Their gut microbiota were analyzed by 16S sequencing and bioinformatics. The levels of fecal short-chain fatty acids (SCFAs) from five UC patients with recurrent symptoms after FMT and individual mice were quantified by liquid chromatography–mass spectrometry (LC–MS). The impact of butyric acid on the abundance and diversity of the gut microbiota was tested in vitro. The effect of the combination of butyric acid-producing bacterium and FMT on the clinical responses of 45 UC patients was retrospectively analyzed. Compared with that in the controls, the FMT significantly increased the abundance of butyric acid-producing bacteria and fecal butyric acid levels in UC patients. The FMT significantly increased the α-diversity, changed gut microbial structure, and elevated fecal butyric acid levels in colitis mice. Anaerobic culture with butyrate significantly increased the α-diversity of the gut microbiota from colitis mice and changed their structure. FMT combination with Clostridium butyricum-containing probiotics significantly prolonged the UC remission in the clinic. Therefore, fecal butyric acid level may be a biomarker for evaluating the efficacy of FMT for UC, and addition of butyrate-producing bacteria may prolong the therapeutic effect of FMT on UC by changing the gut microbiota.

scholarly journals Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson’s disease patients

BMC Neurology ◽  
2022 ◽  
Vol 22 (1) ◽  
Author(s):  
Gang Wu ◽  
Zhengli Jiang ◽  
Yaling Pu ◽  
Shiyong Chen ◽  
Tingling Wang ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Fatty Acids ◽  
Parkinson's Disease ◽  
Serum Concentration ◽  
Gut Microbiota ◽  
Propionic Acid ◽  
Short Chain Fatty Acids ◽  
Short Chain ◽  
Motor Symptoms ◽  
Non Motor Symptoms

Abstract Background Parkinson’s disease (PD) is associated with enteric nervous system dysfunction and gut microbiota dysbiosis. Short-chain fatty acids (SCFAs), derived from gut microbiota, are supposed to anticipate PD pathogenesis via the pathway of spinal cord and vagal nerve or the circulatory system. However, the serum concentration of SCFAs in PD patients is poorly known. This study aims to investigate the exact level of SCFAs in PD patients and its correlation with Parkinson’s symptoms. Methods 50 PD patients and 50 healthy controls were recruited, and their demographic and clinical characteristics were collected. The serum concentration of SCFAs was detected using a gas chromatography-mass spectrometer. SCFAs were compared between PD and control groups. The correlation between serum SCFAs and Parkinson’s symptoms and the potential effects of medications on the serum SCFAs was analyzed. Results Serum propionic acid, butyric acid and caproic acid were lower, while heptanoic acid was higher in PD patients than in control subjects. However, only the serum level of propionic acid was correlated with Unified Parkinson’s Disease Rating Scale (UPDRs) part III score (R = -0.365, P = 0.009), Mini-mental State Examination (MMSE) score (R = -0.416, P = 0.003), and Hamilton Depression Scale (HAMD) score (R = 0.306, P = 0.03). There was no correlation between other serum SCFAs and motor complications. The use of trihexyphenidyl or tizanidine increased the serum concentration of propionic acid. Conclusions Serum SCFAs are altered in PD patients, and the decrease of serum propionic acid level is correlated with motor symptoms, cognitive ability and non-depressed state. Thus, the gut microbial-derived SCFAs potentially affect Parkinson’s symptoms through the blood circulation. Propionic acid supplementation might ameliorate motor and non-motor symptoms of PD patients, although clinical trials are needed to test this hypothesis.

scholarly journals The Effect of Mycotoxins Adsorbents Beta Glucans or Montmorillonite on Bovine Ruminal Fermentation In Vitro

2018 ◽  
Vol 44 (1) ◽  
pp. 6 ◽  
Author(s):  
Marcelo Dal Pozzo ◽  
Julio Viegas ◽  
Gilberto Vilmar Kozloski ◽  
Cristiano Miguel Stefanello ◽  
Alisson Minozzo da Silveira ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Cell Wall ◽  
Acetic Acid ◽  
Propionic Acid ◽  
Butyric Acid ◽  
Short Chain Fatty Acids ◽  
Short Chain ◽  
Ruminal Fermentation ◽  
Ryegrass Hay ◽  
Average Representation

Background: The addition of adsorbents in foods has been the strategy used by nutritionists to reduce the toxic effects of mycotoxins in animals. Mycotoxins are found in a range of foods and commonly they present variations in the chemical structure therefore, it has been appropriate to include adsorbents from different sources in the diet of ruminants. However, few researches were conducted in order to better understand the interaction of adsorbents on ruminal fermentation. Our objective in this study was to investigate the possible effects of two adsorbent products on bovine ruminal fermentation. One consists of 65% of β-glucan (β-glu), originating cell wall of Saccharomyces cerevisiae and used at a concentration of 1% and natural sodium montmorillonite (MMT) at a concentration of 5%.Materials, Methods & Results: The effects of β-glu adsorbents (1%) and MMC (5%) in culture medium that simulated ruminal fermentation were evaluated. Bottles, with a capacity of 120 mL, were used to be filled with substrate such as maize and ryegrass hay ground, nutrient solution (medium of Menke), liquid extracted rumen fistulated bovine and the two adsorbents evaluated, totaling 50 mL. The experiment was conducted with three treatments, named after: control (Cont), β-glu and MMT. In the control treatment adsorbents were not added. Six replicates were used for each treatment and two trials were conducted. One of the tests aimed to determine the fermentation kinetics by means of the gas production after 72 h’ incubation and quantifying the production of methane (CH4) at 48h. While another test aimed to quantify the production of short chain fatty acids (SCFA) - acetic, propionic and butyric acid - and the production of ammonia (NH3) in 24 h incubation. All assays were measured by gas chromatography. The highest total SCFA concentration was observed in β-glu treatment (67.71 mM) significantly superior to CONT (57.7 mM) treatment and MMT (53.28 mM), which was significantly lower than the β-glu treatment, but similar to CONT. The average representation (%) of acetic acid for the treatment MMT (62.9%) was significantly higher than the β-glu treatment (61.0%). The average proportions of propionic acid were similar between treatments, while the average representation (%) of butyric acid production was significantly higher for the β-glu treatment (13.1%) compared to CONT treatments (11.3%) and MMT (11.4%). The amount of NH3 was significantly reduced in MMT (9.6 mM) treatment compared to β-glu treatments (12.2 mM) and CONT (11.3 mM). In another test, the greater volume of gas (mL) was produced by β-glu treatment (103.4 mL), which was significantly greater than the treatments CONT (89.0 mL) and MMT (91.6 mL). The lag time, i.e. the time taken by the bacteria inoculum to develop lead-through in the substrate, in the MMT treatment took 6.2 h, slowing significantly compared to CONT treatments (4.8 h) and β Glu (4.33 h). The concentration of CH4 was significantly lower in MMT treatment (33.0%) compared to the CONT treatments (36.3%) and β-glu (35.68%).Discussion: The glucans which constitute the main cell wall S. cerevisae are the β-glucans with β-1-3 and β-1,6 glycosidic bonds. The largest and most significant concentration of SCFA and gas volume in the β-glu treatment can be explained by the degradation of β-glucans by rumen bacteria. The possible reason of reduced concentration of methane (CH4) in samples collected during 48 h of incubation in MMT treatment stands on the reduction in symbiotic activity of methanogenic bacteria and protozoa. Also, the possible reason of reduction in the concentration of ammonia (NH3) in MMT treatment could be associated to damage on protozoa with proteolytic activity. Our results showed that the amount of montmorillonite in rumen fluid influenced negatively the fermentative activity, therefore, delaying the colonization of bacteria in rumen substrate composed of maize and ryegrass hay. Moreover, the use of β-glu (1%) significantly increased the amount of short chain fatty acids such as, acetic acid and butyric acid, with the exception of propionic acid.

scholarly journals Bacteroides, Butyric Acid and t10,c12-CLA Changes in Colorectal Adenomatous Polyp Patients

2021 ◽  
Author(s):  
Ciyan Chen ◽  
Min Niu ◽  
Junxi Pan ◽  
Na Du ◽  
Shumin Liu ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Butyric Acid ◽  
Precancerous Lesions ◽  
Short Chain Fatty Acids ◽  
Ultra Performance Liquid Chromatography ◽  
Control Group ◽  
16S Rrna Sequence ◽  
Secondary Bile Acid ◽  
Liquid Chromatography Tandem Mass ◽  
Bacterial Genes

Abstract Background: Colorectal adenomatous polyps (CAPs) are considered precancerous lesions of colorectal cancer (CRC). The gut microbiota participates in the process of digestion and, in the process, produces metabolites, mainly short-chain fatty acids (SCFAs), secondary bile acids and conjugated linoleic acid (CLA). This study aimed to investigate the gut microbiota constituents and metabolites in the faeces of CAP patients to identify microbiota or metabolites that can be used as sensitive biological predictors and to provide a theoretical basis for the clinical treatment of CAPs.Methods: 16S rRNA sequence analysis was used to detect microbial changes in the faeces of CAP patients. qPCR analysis was used to evaluate the ability of the microbiota to produce metabolites, and the contents of metabolites in faeces were detected by ion chromatography and ultra-performance liquid chromatography-tandem mass spectrometry(UPLC-MS/MS).Results: Based on the detection of the gut microbiota, patients with CAPs had increased abundances of Bacteroides and Citrobacter, and the abundances of Weissella and Lactobacillus were decreased. We also explored gene expression, and the abundance of butyrate-producing bacterial genes was significantly increased in the faeces of CAP patients, but those of secondary bile acid-producing and CLA-producing bacterial genes showed no differences in faecal samples. The acetic acid and butyric acid contents were increased in the faeces of the CAP group, and the healthy control group had higher t10,c12-CLA contents. Conclusion: The gut microbiota analysis results, assessed in faeces, showed that Bacteroides and Citrobacter were positively correlated with CAPs, which indicated that changes in specific genera might be detrimental to intestinal health. In addition, t10,c12-CLA played an important role in protecting the intestine.

Sign in / Sign up

Export Citation Format

Share Document